UPDATE 1-Eye drug maker Akorn to buy rival Hi-Tech Pharmacal for $640 mln
August 27, 2013 at 08:44 AM EDT
* Akorn expects deal to add to adj earnings/share immediately upon closing
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.